Haemostatic management of obstetric haemorrhage

Anaesthesia

Volumn 70, Issue S1, 2015, Pages

  Collis, R E ^a   Collins, P W ^b,c  

^a Department of Anaesthetics Pain Medicine and Intensive Care   (United Kingdom)

^b CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

^c CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7A; FIBRINOGEN; TRANEXAMIC ACID;

BLOOD TRANSFUSION; FEMALE; HEMOSTASIS; HUMAN; PHYSIOLOGY; PLASMA; POSTPARTUM HEMORRHAGE; PREGNANCY; THROMBOCYTE TRANSFUSION;

BLOOD TRANSFUSION; FACTOR VIIA; FEMALE; FIBRINOGEN; HEMOSTASIS; HEMOSTATIC TECHNIQUES; HUMANS; PLASMA; PLATELET TRANSFUSION; POSTPARTUM HEMORRHAGE; PREGNANCY; TRANEXAMIC ACID;

EID: 84925226535     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/ANAE.12913     Document Type: Article

References (54)

1. World Health Organization. Maternal Mortality: Fact Sheet 348. 2012. http://www.who.int/mediacentre/factsheets/fs348/en/ (accessed 17/09/2014).
2. Say L, Chou D, Gemmill A, et al. Global causes of maternal death: A WHO systematic analysis. Lancet Global Health 2014; 2: E323-3.
3. Lennox C, Marr L. Saving mothers’ lives. Scottish Confidential Audit of Severe Maternal Morbidity. 9th Annual Report (data from 2011). http://healthcareimprovementscotland.org/his/idoc.ashx?docid=5fb640e2-d079-48cc-ad49-a58f6929b685&version=-1 (accessed 17/09/2014).
4. Wilkinson H. Saving mothers’ lives. Reviewing maternal deaths to make motherhood safer: 2006-2008. British Journal of Obstetrics and Gynaecology 2011; 118: 1402-3.
5. Kramer MS, Berg C, Abenhaim H, et al. Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. American Journal of Obstetrics and Gynecology 2013; 209: E1-7.
6. Lutomski JE, Byrne BM, Devane D, Greene RA. Increasing trends in atonic postpartum haemorrhage in Ireland: An 11-year population-based cohort study. British Journal of Obstetrics and Gynaecology 2012; 119: 306-14.
7. Mehrabadi A, Hutcheon JA, Lee L, Kramer MS, Liston RM, Joseph KS. Epidemiological investigation of a temporal increase in atonic postpartum haemorrhage: A populationbased retrospective cohort study. British Journal of Obstetrics and Gynaecology 2013; 120: 853-62.
8. Royal College of Obstetricians and Gynaecologists. Prevention and Management of Postpartum Haemorrhage. Green-top guideline No. 52, 2009. http://www.rcog.org.uk/files/rcogcorp/GT52PostpartumHaemorrhage0411.pdf (accessed 17/09/ 2014).
9. Thomas D, Wee M, Clyburn P, et al. Blood transfusion and the anaesthetist: Management of massive haemorrhage. Anaesthesia 2010; 65: 1153-61.
10. Kenyon S. Intrapartum Care: Care of Healthy Women and Their Babies During Childbirth. National Institute for Health and Care Excellence, 2007. http://www.nice.org.uk/guidance/cg55/chapter/guidance (accessed 17/09/2014).
11. World Health Organization. WHO Guidelines for the Management of Postpartum Haemorrhage and Retained Placenta. http://apps.who.int/iris/bitstream/10665/75411/1/9789241548502_eng.pdf (accessed 17/09/2014).
12. Allard S, Green L, Hunt BJ. How we manage the haematological aspects of major obstetric haemorrhage. British Journal of Haematology 2014; 164: 177-88.
13. Thachil J, Toh CH. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Reviews 2009; 23: 167-76.
14. O’Riordan MN, Higgins JR. Haemostasis in normal and abnormal pregnancy. Best Practice and Research. Clinical Obstetrics and Gynaecology 2003; 17: 385-96.
15. Liu X, Jiang Y, Shi H, Yue X, Wang Y, Yang H. Prospective, sequential, longitudinal study of coagulation changes during pregnancy in Chinese women. International Journal of Gynecology and Obstetrics 2009; 105: 240-3.
16. Szecsi PB, Jorgensen M, Klajnbard A, Andersen MR, Colov NP, Stender S. Haemostatic reference intervals in pregnancy. Thrombosis and Haemostasis 2010; 103: 718-27.
17. Armstrong S, Fernando R, Ashpole K, Simons R, Columb M. Assessment of coagulation in the obstetric population using ROTEM_ thromboelastometry. International Journal of Obstetric Anesthesia 2011; 20: 293-8.
18. Solomon C, Collis RE, Collins PW. Haemostatic monitoring during postpartum haemorrhage and implications for management. British Journal of Anaesthesia 2012; 109: 851-63.
19. Van Rheenen-Flach LE, Zweegman S, Boersma F, Lenglet JE, Twisk JWR, Bolte AC. A prospective longitudinal study on rotation thromboelastometry in women with uncomplicated pregnancies and postpartum. Australian and New Zealand Journal of Obstetrics and Gynaecology 2013; 53: 32-6.
20. De Lange NM, Lance MD, De Groot R, Beckers EAM, Henskens YM, Scheepers HCJ. Obstetric hemorrhage and coagulation: An update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. Obstetrical and Gynecological Survey 2012; 67: 426-35.
21. Hill JS, Devenie G, Powell M. Point-of-care testing of coagulation and fibrinolytic status during postpartum haemorrhage: Developing a thrombelastography_-guided transfusion algorithm. Anaesthesia and Intensive Care 2012; 40: 1007-15.
22. Cerneca F, Ricci G, Simeone R, Malisano M, Alberico S, Guaschino S. Coagulation and fibrinolysis changes in normal pregnancy increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. European Journal of Obstetrics, Gynecology and Reproductive Biology 1997; 73: 31-6.
23. Bonnar J, McNicol GP, Douglas AS. Fibrinolytic enzyme system and pregnancy. British Medical Journal 1969; 3: 387-9.
24. Bonnar J, McNicol GP, Douglas AS. Coagulation and fibrinolytic mechanisms during and after normal childbirth. British Medical Journal 1970; 2: 200-3.
25. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. Journal of Thrombosis and Haemostasis 2007; 5: 266-73.
26. De Lloyd L, Bovington R, Kaye A, et al. Standard haemostatic tests following major obstetric haemorrhage. International Journal of Obstetric Anesthesia 2011; 20: 135-41.
27. Collins PW, Lilley G, Bruynseels D, et al. Fibrin-based clot formation an early and rapidly biomarker for progression of postpartum hemorrhage: A prospective study. Blood 2014; 124: 1727-36.
28. Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesthesia and Analgesia 1995; 81: 360-5.
29. Levi M. Pathogenesis and management of peripartum coagulopathic calamities (disseminated intravascular coagulation and amniotic fluid embolism). Thrombosis Research 2013; 131: S32-4.
30. Fenger-Eriksen C, Moore GW, Rangarajan S, Ingerslev J, Sorensen B. Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders. Transfusion 2010; 50: 2571-6.
31. James AH, McLintock C, Lockhart E. Postpartum hemorrhage: When uterotonics and sutures fail. American Journal of Hematology 2012; 87: S16-22.
32. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. British Journal of Haematology 2009; 145: 24-33.
33. Wada H, Thachil J, Di Nisio M, Kurosawa S, Gando S, Toh CH. Harmonized guidance for disseminated intravascular coagulation from the International Society on Thrombosis and Haemostasis and the current status of anticoagulant therapy in Japan: A rebuttal. Journal of Thrombosis and Haemostasis 2013; 11: 2078-9.
34. Butwick AJ. Postpartum hemorrhage and low fibrinogen levels: The past, present and future. International Journal of Obstetric Anesthesia 2013; 22: 87-91.
35. Cortet M, Deneux-Tharaux C, Dupont C, et al. Association between fibrinogen level and severity of postpartum haemorrhage: Secondary analysis of a prospective trial. British Journal of Anaesthesia 2012; 108: 984-9.
36. De Lloyd L, Collins PW, Kaye A, Collis RE. Early fibrinogen as a predictor of red cell requirements during postpartum haemorrhage. International Journal of Obstetric Anesthesia 2012; 21: S13.
37. Gayat E, Resche-Rigon M, Morel O, et al. Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study. Intensive Care Medicine 2011; 37: 1816-25.
38. Poujade O, Zappa M, Letendre I, Ceccaldi PF, Vilgrain V, Luton D. Predictive factors for failure of pelvic arterial embolization for postpartum hemorrhage. International Journal of Gynaecology and Obstetrics 2012; 117: 119-23.
39. Huissoud C, Carrabin N, Audibert F, et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. International Journal of Obstetrics and Gynaecology 2009; 116: 1097-102.
40. Pasquier P, Gayat E, Rackelboom T, et al. An observational study of the fresh frozen plasma: Red blood cell ratio in postpartum hemorrhage. Anesthesia and Analgesia 2013; 116: 155-61.
41. Saule I, Hawkins N. Transfusion practice in major obstetric haemorrhage: Lessons from trauma. International Journal of Obstetric Anesthesia 2012; 21: 79-83.
42. Mallaiah S, Barclay P, Harrod I, Chevannes C, Bhalla A. Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia 2014 Oct 7; doi:10.1111/anae.12859.
43. Ahmed S, Harrity C, Johnson S, et al. The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage - an observational study. Transfusion Medicine 2012; 22: 344-9.
44. Novikova N, Hofmeyr GL. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews 2010; 7: CD007872.
45. Ducloy-Bouthors AS, Jude B, Duhamel A, et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Critical Care 2011; 15: R117.
46. Bell SF, Rayment R, Collins PW, Collis RE. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. International Journal of Obstetric Anesthesia 2010; 19: 218-23.
47. Glover NJ, Collis RE, Collins P. Fibrinogen concentrate use during major obstetric haemorrhage. Anaesthesia 2010; 65: 1229-30.
48. Gollop ND, Chilcott J, Benton A, Rayment R, Jones J, Collins PW. National audit of the use of fibrinogen concentrate to correct hypofibrinogenaemia. Transfusion Medicine 2012; 22: 350-5.
49. Weinkove R, Rangarajan S. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfusion Medicine 2008; 18: 151-7.
50. Wikkelsoe AJ, Afshari A, Stensballe J, et al. The FIB-PPH trial: Fibrinogen concentrate as initial treatment for postpartum haemorrhage: Study protocol for a randomised controlled trial. Trials 2012; 13: 110.
51. Lilley G, Burkitt St Laurent D, Precious E, et al. Measurement of blood loss during postpartum haemorrhage. International Journal of Obstetric Anesthesia 2014 July 26; doi http://dx.doi.org/10.1016/j.ijoa.2014.07.009.
52. Bose P, Regan F, Paterson-Brown S. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. British Journal of Obstetrics and Gynaecology 2006; 113: 919-24.
53. Rees L, Collis RE, Harries S. Uterotonic and pulmonary oedema: Is there a link? International Journal of Obstetric Anesthesia 2007; 16: S36.
54. Evans AD, Rees L, Collis RE. Postpartum haemorrhages admissions to critical care: Completing the audit cycle. International Journal of Obstetric Anesthesia 2009; 18: S49.